Relative to other lung transplant indications, our SSc group experienced comparable survival, despite the high prevalence of severe esophageal dysfunction. PubMed, Ann Am Thorac Soc, 04/14/2016. (Also see Lung Transplants)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.